HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 63 filers reported holding HARPOON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $28 | – | 38 | -91.2% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 434 | -39.3% | 0.00% | – |
| Q2 2022 | $1,000 | -85.7% | 715 | -48.0% | 0.00% | – |
| Q1 2022 | $7,000 | -83.7% | 1,375 | -76.1% | 0.00% | – |
| Q4 2021 | $43,000 | +43.3% | 5,746 | +50.5% | 0.00% | – |
| Q3 2021 | $30,000 | -97.9% | 3,817 | -96.4% | 0.00% | -100.0% |
| Q2 2021 | $1,452,000 | +433.8% | 104,669 | +704.3% | 0.00% | – |
| Q1 2021 | $272,000 | +36.7% | 13,013 | +8.6% | 0.00% | – |
| Q4 2020 | $199,000 | +28.4% | 11,988 | +31.6% | 0.00% | – |
| Q3 2020 | $155,000 | +198.1% | 9,108 | +192.9% | 0.00% | – |
| Q2 2020 | $52,000 | +18.2% | 3,110 | -18.9% | 0.00% | – |
| Q1 2020 | $44,000 | -13.7% | 3,833 | +10.4% | 0.00% | – |
| Q4 2019 | $51,000 | +104.0% | 3,471 | +92.8% | 0.00% | – |
| Q3 2019 | $25,000 | +25.0% | 1,800 | +14.5% | 0.00% | – |
| Q2 2019 | $20,000 | +233.3% | 1,572 | +129.8% | 0.00% | – |
| Q1 2019 | $6,000 | – | 684 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
| MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
| ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
| Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
| Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
| Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
| DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
| Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |